Contract HT942525F0237
Mapp Biopharmaceutical, Inc. · Department Of Defense · July 9, 2025
Mapp Biopharmaceutical, Inc. was awarded a federal contract by Department Of Defense (Defense Health Agency) on July 9, 2025 for $111,000 (current value) of work in in-vitro diagnostic substance manufacturing. Performance is in San Diego, CA. This is a task or delivery order issued under parent IDIQ HT942525D0009. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 23, 2025. If all options are exercised, the contract could reach $111,000.
Contract details
- PIID
- HT942525F0237
- Parent IDIQ
- HT942525D0009
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Not Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
- Place of performance
- San Diego, CA
- First action
- July 9, 2025
- Latest action
- December 23, 2025
Description
MONOCLONAL ANTIBODIES AND VIRAL RECOMBINANT ANTIGENS
Modification timeline
-
December 23, 2025Mod P00002 · Other Administrative Action$110.5K
-
July 9, 2025Mod P00001 · Supplemental Agreement For Work Within ScopeANTIBODY AND ANTIGEN SUPPLY$110.5K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Diasorin Inc | Department Of Defense | December 31, 2025 | $518.8K |
| Bloodworks | Department Of Defense | December 31, 2025 | $160.2K |
| Sl Meditech Co. | Department Of Defense | December 31, 2025 | $151.6K |
| Alba Bioscience, Inc. | Department Of Defense | December 31, 2025 | $163.2K |
| Werfen USA Llc | Department Of Defense | December 31, 2025 | $18.1K |
| Immucor Inc | Department Of Defense | December 31, 2025 | $154.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HT942525F0237?
Contract HT942525F0237 is a federal contract awarded to Mapp Biopharmaceutical, Inc. by Department Of Defense on July 9, 2025 for $111,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 1 time since the base award.
Who won contract HT942525F0237?
Mapp Biopharmaceutical, Inc. won contract HT942525F0237 from Department Of Defense.
How much is contract HT942525F0237 worth?
Contract HT942525F0237 has obligated $0 to date but carries a potential ceiling of $111,000 if fully funded and all options are exercised.